Date:
Monday, April 8, 2019, 12:00pm to 1:00pm
Location:
Vanderbilt Hall - Vanderbilt Lounge
IndieBio
Coming all the way from San Francisco!
Building Biotech Startups
Monday, April 8th
12:00 - 1:00pm
Lunch will be provided!!
Vanderbilt Lounge
Harvard Medical School
Vanderbilt Hall,
107 Avenue Louis Pasteur, Boston, MA 02115
RSVP HERE!!
Arvind Gupta
IndieBio Founder
SOSV Partner
Alex Kopelyan
Program Director
Partner
Also joining us to talk about their experience:
-David Salzman, CEO of sRNAlytics & IB alum
-Hyunjun Park, CEO of Catalog & IB alum)
Biology has long been confined to the labs of academia and pharmaceutical giants. However we're undergoing an unprecedented shift as biology as a technology is enabling scientist-entrepreneurs to solve global challenges across industries.
At IndieBio, we've funded 105 biotech startups in the last four years, most founded by grad students translating their academic discoveries into solutions in human and planetary health. Today we'll talk about what has changed to kickstart the biotech startup ecosystem, how IndieBio operates, examples of areas and companies funded, and lessons learned from these startups.
About:
IndieBio (http://indiebio.co) is the world’s leading biotechnology accelerator, located in downtown San Francisco. Companies from all over the world apply to be part of a 4 month acceleration program which includes $250,000 funding, dedicated mentorship, and 24/7 access to a co-working space and bio-safety level 1 & 2 labs. During the program, teams are focused on turning science into product, closing customers, raising investment, and developing leadership skills.
Coming all the way from San Francisco!
Building Biotech Startups
Monday, April 8th
12:00 - 1:00pm
Lunch will be provided!!
Vanderbilt Lounge
Harvard Medical School
Vanderbilt Hall,
107 Avenue Louis Pasteur, Boston, MA 02115
RSVP HERE!!
Arvind Gupta
IndieBio Founder
SOSV Partner
Alex Kopelyan
Program Director
Partner
Also joining us to talk about their experience:
-David Salzman, CEO of sRNAlytics & IB alum
-Hyunjun Park, CEO of Catalog & IB alum)
Biology has long been confined to the labs of academia and pharmaceutical giants. However we're undergoing an unprecedented shift as biology as a technology is enabling scientist-entrepreneurs to solve global challenges across industries.
At IndieBio, we've funded 105 biotech startups in the last four years, most founded by grad students translating their academic discoveries into solutions in human and planetary health. Today we'll talk about what has changed to kickstart the biotech startup ecosystem, how IndieBio operates, examples of areas and companies funded, and lessons learned from these startups.
About:
IndieBio (http://indiebio.co) is the world’s leading biotechnology accelerator, located in downtown San Francisco. Companies from all over the world apply to be part of a 4 month acceleration program which includes $250,000 funding, dedicated mentorship, and 24/7 access to a co-working space and bio-safety level 1 & 2 labs. During the program, teams are focused on turning science into product, closing customers, raising investment, and developing leadership skills.